

Emma Waters
Policy analyst at The Heritage Foundation focused on bioethics, reproductive technologies, and the legal and ethical implications of embryo selection and germline editing.
Top 3 podcasts with Emma Waters
Ranked by the Snipd community

21 snips
Feb 19, 2025 • 1h 2min
IVF | Cincinnatus Series
Emma Waters, a senior research associate at the Heritage Foundation, Natalie Dodson from the Ethics and Public Policy Center, and Inez Stepman of the Independent Women's Forum share their insights on the ethical dilemmas surrounding IVF. They discuss the moral implications of embryo discard, genetic selection, and the potential role of AI in reproductive choices. The trio emphasizes the need for thoughtful legislation that prioritizes parental rights while confronting the evolving landscape of bioethics and the complexities of modern parenthood.

8 snips
Nov 13, 2025 • 0sec
WarRoom Battleground EP 891: Tech Bros, Designer Babies, and AI Suicides
Emma Waters, a policy analyst from The Heritage Foundation, dives into the ethical dilemmas surrounding embryo selection and germline editing, arguing against consumer eugenics and the moral implications of destroying embryos. Brendan Steinhauser from the Alliance for Secure AI highlights the dangers of chatbots, spotlighting lawsuits against OpenAI for suicides linked to AI influence, and advocates for state-led regulations to protect children. Together, they explore the intersection of technology, human dignity, and AI accountability.

Jun 6, 2025 • 1h 37min
Debating the Science and Ethics of IVF: Emma Waters vs. Ruxandra Teslo
Ruxandra Teslo, a Genomics Ph.D. student from the University of Cambridge, and Emma Waters, a bioethics policy analyst at The Heritage Foundation, dive deep into the controversial world of in vitro fertilization (IVF). They discuss the ethics of embryo selection and the societal implications of such advancements. Key topics include the moral status of embryos, the impact of reproductive technology on women's careers, and the need for accessible fertility treatments. Their engaging debate raises crucial questions about the future of reproductive health and technology.


